On March 3, 2026, the FDA approved the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 mcg per actuation, for the maintenance treatment of asthma as prophylactic therapy in...
The FDA has proposed new draft guidance to improve the accuracy of pulse oximeters across all skin tones, addressing long-standing concerns about potential disparities in performance.
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
The American Thoracic Society says the FDA approved the asthma treatment with lack of consideration for patient safety and for a public policy process.
In 2010, the FDA mandated that 4 companies marketing long-acting β2 agonists perform trials comparing the safety of combination therapy with LABA plus an inhaled glucocorticoid vs an inhaled glucocorticoid...
To address growing public health concerns, the US Food and Drug Administration is designing a new plan to serve as a roadmap for regulating tobacco products in the future, in order to reduce smoking...
